4//SEC Filing
Cohen Fred E 4
Accession 0000950170-25-080447
CIK 0001994702other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 6:30 PM ET
Size
8.4 KB
Accession
0000950170-25-080447
Insider Transaction Report
Form 4
Cohen Fred E
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2025-05-29+65,351→ 65,351 totalExercise: $2.63Exp: 2035-05-29→ Common Stock (65,351 underlying) - Award
Common Stock
2025-05-29+16,634→ 16,634 total
Holdings
- 4,523,924(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]Represents a restricted stock unit award of common stock, which will vest in full on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
- [F2]All of the shares subject to the option shall be fully vested and exercisable on the earlier of (i) May 29, 2026, and (ii) immediately prior to the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
- [F3]Shares held directly by Vida Ventures, LLC ("Vida"). Vida Ventures Advisors, LLC is the investment advisor to Vida. Dr. Arie Belldegrun, Leonard Potter and the Reporting Person are the managing members of Vida Ventures Advisors, LLC, and may be deemed to share voting and dispositive power over the shares held by Vida, but each disclaims beneficial ownership of the shares held by Vida except to the extent of such person's pecuniary interest therein, if any.
Documents
Issuer
Kyverna Therapeutics, Inc.
CIK 0001994702
Entity typeother
Related Parties
1- filerCIK 0001339358
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 6:30 PM ET
- Size
- 8.4 KB